Reversal of acute ("malignant") myelosclerosis by allogeneic bone marrow transplantation.

Abstract

A 28-yr-old woman with acute malignant myelosclerosis received, as primary treatment, ablative chemotherapy and total body radiation therapy followed by bone marrow transplantation from her histocompatible brother. The patient is now well more than 15 mo after bone marrow transplantation, with normal peripheral blood counts, a normal bone marrow, no evidence of graft-versus-host disease, and is on no therapy. In light of the poor results obtained with conventional chemotherapy in this disease, bone marrow transplantation may represent the treatment of choice for patients who have an appropriate donor.

• Authors: J L Wolf, W E Spruce, R M Bearman, S J Forman, E P Scott, J L Fahey, M J Farbstein, H Rappaport, K G Blume
• Journal: Blood (Blood) Vol. 59 Issue 1 Pg. 191-3 (Jan 1982) ISSN: 0006-4971 [Print] United States
• PMID: 7032626 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Topics

• Acute Disease
• Adult
• Bone Marrow Transplantation
• Female
• Humans
• Primary Myelofibrosis (therapy)